CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

CADTH Welcomes Suzanne McGurn as President and CEO

Published on: July 6, 2020
Result type: News

CADTH is proud to welcome Suzanne McGurn, who begins her role as President and Chief Executive Officer today.

Ms. McGurn was appointed by the CADTH Board of Directors after a comprehensive search that was international in scope. She brings to CADTH significant leadership experience and a deep understanding of the diverse needs of governments, clinicians, patients, and industry.

Prior to joining CADTH, Ms. McGurn was the Assistant Deputy Minister of Institutional Services at the Ontario Ministry of the Solicitor General. Ms. McGurn also served for five years as Ontario’s Assistant Deputy Minister of the Drugs and Devices Division and the Executive Officer of Ontario’s Public Drug Programs. She also led the implementation of the pan-Canadian Pharmaceutical Alliance and served as its first Chair.

In addition to her understanding of the complex issues surrounding the management of pharmaceuticals, medical devices, procedures, and health systems in Canada, Ms. McGurn brings significant experience in governance and patient engagement in the health system. Her past roles on the CADTH Board of Directors include Vice-Chair and Ontario Representative. Further, she has served as the Executive Director of the Alzheimer Society of Kingston, Frontenac, Lennox & Addington and as a Senior Manager at the Kingston, Frontenac, Lennox & Addington Community Care Access Centre.

Ms. McGurn holds both a Bachelor of Nursing Sciences and a Master of Public Administration from Queen’s University.